Hanmi Pharmaceutical Teams Up with Mexican Sanfer to Expand Global Reach of Obesity Drug Hanmi Pharmaceutical has signed an exclusive deal with Mexico's Sanfer for the distribution of efpeglenatide, Korea's first GLP-1 drug for obesity, enhancing global access.

Hanmi Pharmaceutical Teams Up with Mexican Sanfer to Expand Global Reach of Obesity Drug #South_Korea #Seoul #Hanmi #Sanfer #efpeglenatide

Hanmi seeks to gain on Wegovy with its own weight-loss drug Hanmi Pharmaceutical is working on its own range of weight-loss treatments tailored to the Korean market.

#Hanmi Pharmaceutical aims to disrupt the obesity drug market currently led by Eli Lilly and Novo Nordisk with its own diverse range of weight-loss treatments tailored to meet the unique needs of patients, beginning with its obesity drug #Efpeglenatide.